Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations. We help you understand fair value estimates and potential upside or downside scenarios for any stock.
As of 2026-04-06, AstraZeneca PLC Ordinary Shares (AZN) trades at $203.76, marking a 0.13% gain on the day. The global biopharmaceutical firm, which develops therapies spanning oncology, rare diseases, cardiovascular and metabolic conditions, has seen largely range-bound price action in recent weeks, as investors balance sector-specific catalysts and broader market sentiment. This analysis outlines key technical levels, recent market context, and potential near-term scenarios for AZN shares. No
Is AstraZeneca (AZN) Stock Trending Down | Price at $203.76, Up 0.13% - Community Driven Stock Picks
AZN - Stock Analysis
4170 Comments
1462 Likes
1
Carlaya
Influential Reader
2 hours ago
Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health and management confidence. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects and future outlook. We provide 13D filings, insider buying and selling data, and trend analysis for comprehensive coverage. Get inside information with our comprehensive insider tracking and analysis tools for informed investment decisions.
👍 98
Reply
2
Henriette
Power User
5 hours ago
I read this and now I feel different.
👍 241
Reply
3
Shaima
Returning User
1 day ago
Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
👍 249
Reply
Timing really wasn’t on my side.
👍 199
Reply
5
Kynzly
New Visitor
2 days ago
Investors are closely watching economic indicators, which could influence market direction in the coming sessions.
👍 163
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.